» Articles » PMID: 22174352

Calcified Neurocysticercosis Among Patients with Primary Headache

Overview
Journal Cephalalgia
Specialties Neurology
Psychiatry
Date 2011 Dec 17
PMID 22174352
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anecdotal reports and a single case-control epidemiological survey have suggested an association between the helminthic disease neurocysticercosis and primary headache. The present study was undertaken to determine whether neurocysticercosis is more common among patients with primary headaches than in other neurological disorders.

Methods: We determined the prevalence of neurocysticercosis in a cohort of patients with primary headache who were seen at our institution over a 20-year period. We used as controls all people from the same cohort with four major different categories of neurological disorders, including cerebrovascular disease, degenerative disorders of the CNS, head trauma, and primary brain tumors. We evaluated differences in the prevalence of neurocysticercosis between patients and controls.

Results: Forty-eight of 1017 patients with primary headache and 31 of 1687 controls had neurocysticercosis (4.7% vs 1.8%, p < 0.0001). Calcified parenchymal brain cysticerci were more frequent among patients with primary headache than in those with cerebrovascular disease (4.7% vs 1%, p < 0.001), degenerative disorders of the CNS (4.7% vs 2.4%, p < 0.05), and head trauma (4.7% vs 2.3%, p < 0.05). There were no significant differences, however, for the subset of controls with primary brain tumors (4.7% vs 3.5%), a condition that has also been associated with neurocysticercosis.

Conclusions: There is a relationship between calcified neurocysticercosis and primary headache disorders. It is possible that periodic remodeling of cysticercotic calcifications, with liberation of antigens to the brain parenchyma, contributes to the occurrence of headache in these patients.

Citing Articles

Calcified Neurocysticercosis: Demographic, Clinical, and Radiological Characteristics of a Large Hospital-Based Patient Cohort.

Bustos J, Arroyo G, Del Brutto O, Gonzales I, Saavedra H, Guzman C Pathogens. 2024; 13(1).

PMID: 38251334 PMC: 10820744. DOI: 10.3390/pathogens13010026.


Human Neurocysticercosis: An Overview.

Del Brutto O Pathogens. 2022; 11(10).

PMID: 36297269 PMC: 9607454. DOI: 10.3390/pathogens11101212.


Does Calcified Neurocysticercosis Affect Migraine Characteristics and Treatment Responsiveness? A Case-Control Study.

Sharma K, Uniyal R, Garg R, Verma R, Paliwal V, Malhotra H Am J Trop Med Hyg. 2022; 107(6):1190-1195.

PMID: 36216323 PMC: 9768286. DOI: 10.4269/ajtmh.22-0335.


A scoping review of burden of disease studies estimating disability-adjusted life years due to Taenia solium.

Larkins A, Bruce M, Di Bari C, Devleesschauwer B, Pigott D, Ash A PLoS Negl Trop Dis. 2022; 16(7):e0010567.

PMID: 35793356 PMC: 9292123. DOI: 10.1371/journal.pntd.0010567.


Neurocysticercosis presenting as psychosis: A case report and a brief literature review.

Ahmed S, Usmani S, Javed S, Hans A, Saboor S, Hanif A SAGE Open Med Case Rep. 2022; 10:2050313X221100396.

PMID: 35615741 PMC: 9125614. DOI: 10.1177/2050313X221100396.